In this video, Marta Skrodzka, MD, PhD, FEBU, FECSM, FEAA, Jai Seth, MD, BSc, MSc, FRCS, and Netty Kinsella, RN, MSc, PhD, discuss upcoming research in the areas of individualized care, sexual dysfunction, and stratified follow-up. This discussion is part of a larger forum on prostate cancer survivorship. Skrodzka is a consultant urologist and Seth is a urology consultant at St George’s University Hospital, and Kinsella is a uro-oncology nurse consultant at the Royal Marsden NHS Foundation Trust in London, United Kingdom.
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.